Log in

CVE:IPA - Immunoprecise Antibodies Stock Price, Forecast & News

+0.01 (+2.00 %)
(As of 12/16/2019 09:09 AM ET)
Today's Range
Now: C$0.51
50-Day Range
MA: C$0.59
52-Week Range
Now: C$0.51
Volume75,700 shs
Average Volume71,303 shs
Market CapitalizationC$34.67 million
P/E RatioN/A
Dividend YieldN/A
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services. The company has a collaboration agreement with TetraGenetics, Inc. The company was founded in 1989 and is based in Victoria, Canada.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesC$10.77 million
Cash FlowC$0.07 per share
Book ValueC$0.23 per share



Market CapC$34.67 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IPA News and Ratings via Email

Sign-up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter.

Immunoprecise Antibodies (CVE:IPA) Frequently Asked Questions

What is Immunoprecise Antibodies' stock symbol?

Immunoprecise Antibodies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IPA."

Has Immunoprecise Antibodies been receiving favorable news coverage?

Press coverage about IPA stock has trended somewhat negative on Monday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Immunoprecise Antibodies earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Immunoprecise Antibodies.

Who are some of Immunoprecise Antibodies' key competitors?

What other stocks do shareholders of Immunoprecise Antibodies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunoprecise Antibodies investors own include Northwest Pipe (NWPX), Adaptimmune Therapeutics (ADAP), Acadia Healthcare (ACHC), WPP (WPP), South32 (S32), Faron Pharmaceuticals Oy (FARN), Infineon Technologies (IFXA), Daimler (DAI), Tres Or Resources (TRS) and Prism Medical (PM).

Who are Immunoprecise Antibodies' key executives?

Immunoprecise Antibodies' management team includes the folowing people:
  • Dr. James S. Kuo M.B.A., M.D., Chairman (Age 54)
  • Dr. Jennifer Bath, Pres, CEO & Director
  • Mr. Robert Beecroft, Founder & Director
  • Mr. Charles Wheelock, Global Chief Technology Officer
  • Ms. Lisa Helbling, Chief Financial Officer

How do I buy shares of Immunoprecise Antibodies?

Shares of IPA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Immunoprecise Antibodies' stock price today?

One share of IPA stock can currently be purchased for approximately C$0.51.

How big of a company is Immunoprecise Antibodies?

Immunoprecise Antibodies has a market capitalization of C$34.67 million and generates C$10.77 million in revenue each year. View Additional Information About Immunoprecise Antibodies.

What is Immunoprecise Antibodies' official website?

The official website for Immunoprecise Antibodies is http://immunoprecise.com/.

How can I contact Immunoprecise Antibodies?

Immunoprecise Antibodies' mailing address is 880-580 Hornby St, VANCOUVER, BC V6C 3B6, Canada. The company can be reached via phone at +1-604-8060626.

MarketBeat Community Rating for Immunoprecise Antibodies (CVE IPA)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  98
MarketBeat's community ratings are surveys of what our community members think about Immunoprecise Antibodies and other stocks. Vote "Outperform" if you believe IPA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel